Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Green Wyche T III
 2. Date of Event Requiring Statement (Month/Day/Year)
02/01/2012		 3. Issuer Name and Ticker or Trading Symbol
GREENWAY MEDICAL TECHNOLOGIES INC [GWAY]
(Last)
(First)
(Middle)
121 GREENWAY BOULEVARD		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Pres and Chief Exec. Officer
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

CARROLLTON, GA 30117		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 15,915
D
 
Common Stock 9,250
I
By IRA
Common Stock 12,500
I
By Spouse
Common Stock 198,764
I
By T&J Green Family Partnership LP

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Series A Convertible Preferred Stock   (1)   (1) Common Stock 11,677 (1) $ (1) D  
Employee Stock Option (right to buy)   (2) 08/01/2012 Common Stock 34,044 $ 4.75 D  
Employee Stock Option (right to buy)   (2) 02/16/2015 Common Stock 20,000 $ 4.75 D  
Employee Stock Option (right to buy)   (2) 08/18/2015 Common Stock 54,700 $ 4.75 D  
Employee Stock Option (right to buy)   (2) 10/18/2017 Common Stock 75,701 $ 4.75 D  
Employee Stock Option (right to buy)   (2) 09/18/2018 Common Stock 4,184 $ 4.75 D  
Employee Stock Option (right to buy)   (2) 09/15/2019 Common Stock 500 $ 5.19 D  
Employee Stock Option (right to buy)   (3) 11/04/2019 Common Stock 30,000 $ 5.19 D  
Employee Stock Option (right to buy)   (4) 10/18/2020 Common Stock 15,000 $ 6.92 D  
Employee Stock Option (right to buy)   (5) 02/01/2021 Common Stock 125,000 $ 7.09 D  
Employee Stock Option (right to buy)   (6) 07/14/2021 Common Stock 15,000 $ 13.31 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Green Wyche T III
121 GREENWAY BOULEVARD
CARROLLTON, GA 30117		   X     Pres and Chief Exec. Officer  

Signatures

/s/ William G. Esslinger, Jr., attorney-in-fact 02/01/2012
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Each share of Series A Convertible Preferred Stock will automatically convert into 1.263 shares of common stock in connection with the completion of the Company's initial public offering and has no expiration date.
(2) All options to purchase shares of common stock are currently exercisable.
(3) The option vests over four years, with 25% vesting on November 4, 2010 and the remainder vesting over three years thereafter in monthly installments.
(4) The option vests over four years, with 25% vesting on August 4, 2011 and the remainder vesting over three years thereafter in monthly installments.
(5) The option vests over four years, with 25% vesting on February 1, 2012 and the remainder vesting over three years thereafter in monthly installments.
(6) The option vests over four years, with 25% vesting on July 14, 2012 and the remainder vesting over three years thereafter in monthly installments.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.